Back to top

Analyst Blog

Express Scripts Holding Company’s (ESRX - Analyst Report) first quarter 2013 adjusted earnings of 99 cents per share beat the Zacks Consensus Estimate by a penny and increased 35.6% from the year-ago period. Higher revenues aided earnings in the first quarter of 2013.

On a reported basis (including special items), earnings declined 18.1% to 45 cents in the first quarter of 2013.

Quarter in Detail

Revenues jumped 114.8% year over year in the reported quarter to $26.0 billion, marginally beating the Zacks Consensus Estimate of $25.6 billion. The massive jump was attributable to the expanded product portfolio at Express Scripts due to the acquisition of Medco Health Solutions in 2011.

Adjusted gross profit jumped 137.0% to $2.0 billion in the reported quarter. Gross profit was boosted by the inclusion of results of the erstwhile Medco Health Solutions, which led to improved operating performance, increased generic utilization and realization of synergies.

Adjusted selling, general and administrative expenses climbed 137.4% to $541.7 million. Total adjusted claims at Express Scripts for the reported quarter came in at $390.0 million, up 102%.

Cash flow from operations came in at $963.4 million, up from $532.1 million in the first quarter of 2012.  Express Scripts repurchased 5.1 million shares for $300.0 million and repaid $1.5 billion of its long-term debt in the first quarter of 2013.

2013 Earnings Outlook Upped

Apart from announcing first quarter 2013 results, Express Scripts upped its earnings guidance for 2013. The company now expects adjusted earnings in the range of $4.23 - $4.33 per share, up 13%-16% year over year, as opposed to its earlier projected range of $4.20-$4.30 per share. The Zacks Consensus Estimate of $4.27 per share is well within the company’s projected range. The guidance was increased based on the company’s expectation of improvement in gross profit.

For the second quarter of 2013, Express Scripts expects adjusted earnings in the range of $1.08–$1.12 per share. The Zacks Consensus Estimate currently stands at $1.05.

Currently, Express Scripts carries a Zacks Rank #4 (Sell). Right now, Omnicare (OCR - Snapshot Report), Catamaran Corporation (CTRX - Snapshot Report) and MedAssets (MDAS - Snapshot Report) look better placed with a Zacks Rank #2 (Buy).
 

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
SYNAPTICS I… SYNA 78.11 +8.14%
CENTURY ALU… CENX 19.88 +5.74%
GREEN PLAIN… GPRE 39.41 +5.12%
PILGRIM'S P… PPC 28.82 +3.08%
THE PANTRY… PTRY 18.41 +2.79%